Non-opioid Pain Patch Market Size, Share & Trends Analysis Report By Product (Lidocaine Patches, Diclofenac Patches, Indomethacin Patches, Counter-Irritant Patches, Fentanyl Patches, Others), By Applications (Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores), By End Use, By Region, and Segment Forecasts - 2035

Detailed TOC of Global Non-opioid Pain Patch Market Research Report 2026

1 Market Overview
1.1 Non-opioid Pain Patch Product Introduction
1.2 Global Non-opioid Pain Patch Market Size Forecast
1.2.1 Global Non-opioid Pain Patch Sales Value (2021-2035)
1.2.2 Global Non-opioid Pain Patch Sales Volume (2021-2035)
1.2.3 Global Non-opioid Pain Patch Sales Price (2021-2035)
1.3 Non-opioid Pain Patch Market Trends & Drivers
1.3.1 Non-opioid Pain Patch Industry Trends
1.3.2 Non-opioid Pain Patch Market Drivers & Opportunity
1.3.3 Non-opioid Pain Patch Market Challenges
1.3.4 Non-opioid Pain Patch Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-opioid Pain Patch Players Revenue Ranking (2025)
2.2 Global Non-opioid Pain Patch Revenue by Company (2021-2026)
2.3 Global Non-opioid Pain Patch Players Sales Volume Ranking (2025)
2.4 Global Non-opioid Pain Patch Sales Volume by Company Players (2021-2026)
2.5 Global Non-opioid Pain Patch Average Price by Company (2021-2026)
2.6 Key Manufacturers Non-opioid Pain Patch Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-opioid Pain Patch Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-opioid Pain Patch
2.9 Non-opioid Pain Patch Market Competitive Analysis
2.9.1 Non-opioid Pain Patch Market Concentration Rate (2021-2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-opioid Pain Patch Revenue in 2025
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Patch as of 2025)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Lidocaine Patches
3.1.2 Diclofenac Patches
3.1.3 Indomethacin Patches
3.1.4 Counter-Irritant Patches
3.1.5 Fentanyl Patches
3.1.6 Others
3.2 Global Non-opioid Pain Patch Sales Value by Type
3.2.1 Global Non-opioid Pain Patch Sales Value by Type (2021 VS 2025 VS 2035)
3.2.2 Global Non-opioid Pain Patch Sales Value, by Type (2021-2035)
3.2.3 Global Non-opioid Pain Patch Sales Value, by Type (%) (2021-2035)
3.3 Global Non-opioid Pain Patch Sales Volume by Type
3.3.1 Global Non-opioid Pain Patch Sales Volume by Type (2021 VS 2025 VS 2035)
3.3.2 Global Non-opioid Pain Patch Sales Volume, by Type (2021-2035)
3.3.3 Global Non-opioid Pain Patch Sales Volume, by Type (%) (2021-2035)
3.4 Global Non-opioid Pain Patch Average Price by Type (2021-2035)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 OTC
4.1.2 Rx
4.2 Global Non-opioid Pain Patch Sales Value by Application
4.2.1 Global Non-opioid Pain Patch Sales Value by Application (2021 VS 2025 VS 2035)
4.2.2 Global Non-opioid Pain Patch Sales Value, by Application (2021-2035)
4.2.3 Global Non-opioid Pain Patch Sales Value, by Application (%) (2021-2035)
4.3 Global Non-opioid Pain Patch Sales Volume by Application
4.3.1 Global Non-opioid Pain Patch Sales Volume by Application (2021 VS 2025 VS 2035)
4.3.2 Global Non-opioid Pain Patch Sales Volume, by Application (2021-2035)
4.3.3 Global Non-opioid Pain Patch Sales Volume, by Application (%) (2021-2035)
4.4 Global Non-opioid Pain Patch Average Price by Application (2021-2035)
5 Segmentation by Region
5.1 Global Non-opioid Pain Patch Sales Value by Region
5.1.1 Global Non-opioid Pain Patch Sales Value by Region: 2021 VS 2025 VS 2035
5.1.2 Global Non-opioid Pain Patch Sales Value by Region (2021-2026)
5.1.3 Global Non-opioid Pain Patch Sales Value by Region (2026-2035)
5.1.4 Global Non-opioid Pain Patch Sales Value by Region (%), (2021-2035)
5.2 Global Non-opioid Pain Patch Sales Volume by Region
5.2.1 Global Non-opioid Pain Patch Sales Volume by Region: 2021 VS 2025 VS 2035
5.2.2 Global Non-opioid Pain Patch Sales Volume by Region (2021-2026)
5.2.3 Global Non-opioid Pain Patch Sales Volume by Region (2026-2035)
5.2.4 Global Non-opioid Pain Patch Sales Volume by Region (%), (2021-2035)
5.3 Global Non-opioid Pain Patch Average Price by Region (2021-2035)
5.4 North America
5.4.1 North America Non-opioid Pain Patch Sales Value, 2021-2035
5.4.2 North America Non-opioid Pain Patch Sales Value by Country (%), 2025 VS 2035
5.5 Europe
5.5.1 Europe Non-opioid Pain Patch Sales Value, 2021-2035
5.5.2 Europe Non-opioid Pain Patch Sales Value by Country (%), 2025 VS 2035
5.6 Asia Pacific
5.6.1 Asia Pacific Non-opioid Pain Patch Sales Value, 2021-2035
5.6.2 Asia Pacific Non-opioid Pain Patch Sales Value by Country (%), 2025 VS 2035
5.7 South America
5.7.1 South America Non-opioid Pain Patch Sales Value, 2021-2035
5.7.2 South America Non-opioid Pain Patch Sales Value by Country (%), 2025 VS 2035
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-opioid Pain Patch Sales Value, 2021-2035
5.8.2 Middle East & Africa Non-opioid Pain Patch Sales Value by Country (%), 2025 VS 2035
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-opioid Pain Patch Sales Value Growth Trends, 2021 VS 2025 VS 2035
6.2 Key Countries/Regions Non-opioid Pain Patch Sales Value
6.2.1 Key Countries/Regions Non-opioid Pain Patch Sales Value, 2021-2035
6.2.2 Key Countries/Regions Non-opioid Pain Patch Sales Volume, 2021-2035
6.3 United States
6.3.1 United States Non-opioid Pain Patch Sales Value, 2021-2035
6.3.2 United States Non-opioid Pain Patch Sales Value by Type (%), 2025 VS 2035
6.3.3 United States Non-opioid Pain Patch Sales Value by Application, 2025 VS 2035
6.4 Europe
6.4.1 Europe Non-opioid Pain Patch Sales Value, 2021-2035
6.4.2 Europe Non-opioid Pain Patch Sales Value by Type (%), 2025 VS 2035
6.4.3 Europe Non-opioid Pain Patch Sales Value by Application, 2025 VS 2035
6.5 China
6.5.1 China Non-opioid Pain Patch Sales Value, 2021-2035
6.5.2 China Non-opioid Pain Patch Sales Value by Type (%), 2025 VS 2035
6.5.3 China Non-opioid Pain Patch Sales Value by Application, 2025 VS 2035
6.6 Japan
6.6.1 Japan Non-opioid Pain Patch Sales Value, 2021-2035
6.6.2 Japan Non-opioid Pain Patch Sales Value by Type (%), 2025 VS 2035
6.6.3 Japan Non-opioid Pain Patch Sales Value by Application, 2025 VS 2035
6.7 South Korea
6.7.1 South Korea Non-opioid Pain Patch Sales Value, 2021-2035
6.7.2 South Korea Non-opioid Pain Patch Sales Value by Type (%), 2025 VS 2035
6.7.3 South Korea Non-opioid Pain Patch Sales Value by Application, 2025 VS 2035
6.8 Southeast Asia
6.8.1 Southeast Asia Non-opioid Pain Patch Sales Value, 2021-2035
6.8.2 Southeast Asia Non-opioid Pain Patch Sales Value by Type (%), 2025 VS 2035
6.8.3 Southeast Asia Non-opioid Pain Patch Sales Value by Application, 2025 VS 2035
6.9 India
6.9.1 India Non-opioid Pain Patch Sales Value, 2021-2035
6.9.2 India Non-opioid Pain Patch Sales Value by Type (%), 2025 VS 2035
6.9.3 India Non-opioid Pain Patch Sales Value by Application, 2025 VS 2035
7 Company Profiles
7.1 Hisamitsu
7.1.1 Hisamitsu Company Information
7.1.2 Hisamitsu Introduction and Business Overview
7.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Hisamitsu Non-opioid Pain Patch Product Offerings
7.1.5 Hisamitsu Recent Development
7.2 Mylan
7.2.1 Mylan Company Information
7.2.2 Mylan Introduction and Business Overview
7.2.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Mylan Non-opioid Pain Patch Product Offerings
7.2.5 Mylan Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Information
7.3.2 Johnson & Johnson Introduction and Business Overview
7.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Johnson & Johnson Non-opioid Pain Patch Product Offerings
7.3.5 Johnson & Johnson Recent Development
7.4 Actavis
7.4.1 Actavis Company Information
7.4.2 Actavis Introduction and Business Overview
7.4.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Actavis Non-opioid Pain Patch Product Offerings
7.4.5 Actavis Recent Development
7.5 Lingrui
7.5.1 Lingrui Company Information
7.5.2 Lingrui Introduction and Business Overview
7.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Lingrui Non-opioid Pain Patch Product Offerings
7.5.5 Lingrui Recent Development
7.6 Teikoku Seiyaku
7.6.1 Teikoku Seiyaku Company Information
7.6.2 Teikoku Seiyaku Introduction and Business Overview
7.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Teikoku Seiyaku Non-opioid Pain Patch Product Offerings
7.6.5 Teikoku Seiyaku Recent Development
7.7 Sanofi
7.7.1 Sanofi Company Information
7.7.2 Sanofi Introduction and Business Overview
7.7.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Sanofi Non-opioid Pain Patch Product Offerings
7.7.5 Sanofi Recent Development
7.8 Novartis
7.8.1 Novartis Company Information
7.8.2 Novartis Introduction and Business Overview
7.8.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Novartis Non-opioid Pain Patch Product Offerings
7.8.5 Novartis Recent Development
7.9 Qizheng
7.9.1 Qizheng Company Information
7.9.2 Qizheng Introduction and Business Overview
7.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Qizheng Non-opioid Pain Patch Product Offerings
7.9.5 Qizheng Recent Development
7.10 Endo
7.10.1 Endo Company Information
7.10.2 Endo Introduction and Business Overview
7.10.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Endo Non-opioid Pain Patch Product Offerings
7.10.5 Endo Recent Development
7.11 Huarun 999
7.11.1 Huarun 999 Company Information
7.11.2 Huarun 999 Introduction and Business Overview
7.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Huarun 999 Non-opioid Pain Patch Product Offerings
7.11.5 Huarun 999 Recent Development
7.12 GSK
7.12.1 GSK Company Information
7.12.2 GSK Introduction and Business Overview
7.12.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.12.4 GSK Non-opioid Pain Patch Product Offerings
7.12.5 GSK Recent Development
7.13 Haw Par
7.13.1 Haw Par Company Information
7.13.2 Haw Par Introduction and Business Overview
7.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Haw Par Non-opioid Pain Patch Product Offerings
7.13.5 Haw Par Recent Development
7.14 Nichiban
7.14.1 Nichiban Company Information
7.14.2 Nichiban Introduction and Business Overview
7.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Nichiban Non-opioid Pain Patch Product Offerings
7.14.5 Nichiban Recent Development
7.15 Mentholatum
7.15.1 Mentholatum Company Information
7.15.2 Mentholatum Introduction and Business Overview
7.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Mentholatum Non-opioid Pain Patch Product Offerings
7.15.5 Mentholatum Recent Development
7.16 Laboratoires Genevrier
7.16.1 Laboratoires Genevrier Company Information
7.16.2 Laboratoires Genevrier Introduction and Business Overview
7.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Laboratoires Genevrier Non-opioid Pain Patch Product Offerings
7.16.5 Laboratoires Genevrier Recent Development
7.17 BLUE-EMU
7.17.1 BLUE-EMU Company Information
7.17.2 BLUE-EMU Introduction and Business Overview
7.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2021-2026)
7.17.4 BLUE-EMU Non-opioid Pain Patch Product Offerings
7.17.5 BLUE-EMU Recent Development
8 Industry Chain Analysis
8.1 Non-opioid Pain Patch Industrial Chain
8.2 Non-opioid Pain Patch Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-opioid Pain Patch Sales Model
8.5.2 Sales Channel
8.5.3 Non-opioid Pain Patch Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer